Selank protocol
Selank (tuftsin analog). Dosing on this page comes from a published human trial or an approved product label, cited below.
How Selank works
A synthetic analog of the immunopeptide tuftsin, again with a Pro-Gly-Pro tail for stability. It is studied as an anxiolytic without the sedation or dependence associated with benzodiazepines, with effects reported on GABAergic and monoamine signalling.
Selank dosing schedule
Like Semax, Selank is registered in Russia as an intranasal solution and studied there in generalised anxiety indications. The same two caveats apply: the literature is largely Russian-language, and the registered product is nasal drops rather than the injectable research vial.
| Phase | Amount | Frequency | Notes |
|---|---|---|---|
| Registered intranasal use | 0.15% solution | Drops per nostril, daily | The registered presentation, expressed as drops of a stated concentration. |
Study length: Courses of roughly 14 days appear in the published clinical work.
Reconstitution and measurement
This part is arithmetic and does not depend on the evidence level. Concentration is vial size divided by the bacteriostatic water you add. Draw volume is your target amount divided by that concentration. Units are draw volume times 100, because a U-100 syringe reads 100 units per millilitre. Common vials for Selank: 10 mg.
Storage and stability
Reported effects
- Reported in the Russian clinical literature as well tolerated, without the sedation or withdrawal profile of benzodiazepines.
- Independent Western replication is limited.
- No approval outside Russia and neighbouring countries.
Sourcing Selank
Whatever you are working with, the documentation matters more than the price. Ask for a batch certificate of analysis whose lot number matches the vial you actually receive — a COA for a different batch tells you nothing about yours.
Selank at Summit Research Supply → Grade a COA first
Summit is the supplier we feature and an affiliate link. Our COA checklist applies the same way to any vendor.
